A report by HHS' Office of Inspector General stressed that CMS should give suppliers and Medicare beneficiaries more information on proper Medicare billing practices for diabetes test strips to address questionable payments for the products. The OIG also encouraged CMS to "closely monitor suppliers that are awarded [a national mail order] contract ... [and] also monitor non-NMO suppliers that did not win contracts."

Related Summaries